Literature DB >> 19083605

Health related quality of life in patients with Charcot arthropathy of the foot and ankle.

Michael P Sochocki1, Shawn Verity, Pamela J Atherton, Jefrey L Huntington, Jeff A Sloan, John M Embil, Elly Trepman.   

Abstract

BACKGROUND: Clinical observation suggests that Charcot arthropathy of the foot and ankle has major negative consequences on the quality of life of neuropathic patients, particularly those with diabetes. We hypothesized that the quality of life in patients with Charcot arthropathy may be aggravated by Aboriginal ethnicity and rural residence because of limited access to timely specialty healthcare.
METHODS: Sixty patients with Charcot arthropathy were interviewed with the Short Form 36 (SF-36) Health Survey.
RESULTS: Mean Physical Component Summary (PCS) score was 31+/-8 points and mean Mental Component Summary (MCS) score was 45+/-10 points. Mean PCS and MCS scores were not affected by gender, ethnicity, residence, or Charcot stage. Mean PCS score was significantly lower in non-employed (unemployed or retired) than employed patients and in patients who did not use alcohol than those who used alcohol; MCS score was not affected by employment status or alcohol use.
CONCLUSIONS: Charcot arthropathy has a major negative effect on quality of life. The SF-36 survey was sensitive to the physical effects, but not to mental effects, of Charcot arthropathy.

Entities:  

Mesh:

Year:  2007        PMID: 19083605     DOI: 10.1016/j.fas.2007.07.003

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  10 in total

1.  Correlation of SF-36 and SF-12 Component Scores in Patients With Diabetic Foot Disease.

Authors:  Dane K Wukich; Tresa L Sambenedetto; Natalie M Mota; Natalie C Suder; Bedda L Rosario
Journal:  J Foot Ankle Surg       Date:  2016-03-24       Impact factor: 1.286

Review 2.  Measures of health-related quality of life in diabetes-related foot disease: a systematic review.

Authors:  F R A Hogg; G Peach; P Price; M M Thompson; R J Hinchliffe
Journal:  Diabetologia       Date:  2012-01-14       Impact factor: 10.122

3.  Midfoot Charcot Neuroarthropathy in Patients With Diabetes: The Impact of Foot Ulceration on Self-Reported Quality of Life.

Authors:  Katherine M Raspovic; Kimberlee B Hobizal; Bedda L Rosario; Dane K Wukich
Journal:  Foot Ankle Spec       Date:  2015-05-08

4.  A case of diabetic Charcot arthropathy of the foot and ankle.

Authors:  John M Embil; Elly Trepman
Journal:  Nat Rev Endocrinol       Date:  2009-10       Impact factor: 43.330

5.  A qualitative study to understand people's experiences of living with Charcot neuroarthropathy.

Authors:  Catherine Gooday; Wendy Hardeman; Frances Game; Jim Woodburn; Fiona Poland
Journal:  Diabet Med       Date:  2022-01-14       Impact factor: 4.213

6.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

7.  High levels of anxiety and depression in diabetic patients with Charcot foot.

Authors:  Zahra Chapman; Charles Matthew James Shuttleworth; Jörg Wolfgang Huber
Journal:  J Foot Ankle Res       Date:  2014-03-21       Impact factor: 2.303

8.  Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory.

Authors:  Linda Wennberg; Paul Lundgren; Rimma Axelsson; Peter Aspelin; Kurt Gerok-Andersson; Börje Åkerlund
Journal:  J Clin Transl Endocrinol       Date:  2017-06-29

9.  Multi-System Factors Associated with Metatarsophalangeal Joint Deformity in Individuals with Type 2 Diabetes.

Authors:  Jennifer A Zellers; Michael J Mueller; Paul K Commean; Ling Chen; Hyo-Jung Jeong; Mary K Hastings
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

10.  A radiological severity scale to measure the impact of Charcot's Neuroarthropathy: an observational study.

Authors:  Shan Bergin; Parm Naidoo; Cylie M Williams
Journal:  J Foot Ankle Res       Date:  2020-02-11       Impact factor: 2.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.